Swiss National Bank boosted its holdings in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 1.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 171,900 shares of the company’s stock after acquiring an additional 2,900 shares during the period. Swiss National Bank’s holdings in AdaptHealth were worth $1,636,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Blue Trust Inc. increased its holdings in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after purchasing an additional 1,115 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after acquiring an additional 1,690 shares during the period. Rhumbline Advisers raised its holdings in AdaptHealth by 0.5% in the 4th quarter. Rhumbline Advisers now owns 313,110 shares of the company’s stock valued at $2,981,000 after acquiring an additional 1,691 shares in the last quarter. Assetmark Inc. bought a new stake in shares of AdaptHealth during the 4th quarter valued at $28,000. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of AdaptHealth by 10.4% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 30,716 shares of the company’s stock worth $292,000 after purchasing an additional 2,902 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on AHCO. Truist Financial boosted their price target on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. UBS Group cut their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Royal Bank of Canada lifted their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Canaccord Genuity Group upped their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Finally, Robert W. Baird lifted their price target on AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $13.80.
AdaptHealth Price Performance
AHCO stock opened at $10.64 on Friday. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of -6.45, a P/E/G ratio of 1.08 and a beta of 1.30. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The company has a 50 day simple moving average of $10.02 and a 200 day simple moving average of $10.17. AdaptHealth Corp. has a 1 year low of $8.35 and a 1 year high of $11.90.
About AdaptHealth
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Further Reading
- Five stocks we like better than AdaptHealth
- Consumer Discretionary Stocks Explained
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to Short Nasdaq: An Easy-to-Follow Guide
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Calculate Return on Investment (ROI)
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding AHCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdaptHealth Corp. (NASDAQ:AHCO – Free Report).
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.